AAD 2026: 6 Psoriasis Trials to Know

Psoriasis as a disease state commanded a notable share of the late-breaking data presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, with research spanning a broad and rapidly evolving therapeutic landscape, from established biologics accumulating long-term comparative and extension data to emerging oral medications designed to meaningfully shift how psoriasis is managed in the years to come.